Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat

Abstract Background Intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) is the standard treatment for acute ischemic stroke. Standard-dose rt-PA (0.9 mg/kg) is known to achieve good recanalization but carries a high bleeding risk. Lower dose of rt-PA has less bleeding ris...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Hsi-Lung Hsieh, Ching-Chung Liang, Cheng-You Lu, Jen-Tsung Yang, Chiu-Yen Chung, Yu-Shien Ko, Tsong-Hai Lee
Formaat: Artikel
Taal:English
Gepubliceerd in: BMC 2021-10-01
Reeks:Stem Cell Research & Therapy
Onderwerpen:
Online toegang:https://doi.org/10.1186/s13287-021-02615-z
_version_ 1830284163237806080
author Hsi-Lung Hsieh
Ching-Chung Liang
Cheng-You Lu
Jen-Tsung Yang
Chiu-Yen Chung
Yu-Shien Ko
Tsong-Hai Lee
author_facet Hsi-Lung Hsieh
Ching-Chung Liang
Cheng-You Lu
Jen-Tsung Yang
Chiu-Yen Chung
Yu-Shien Ko
Tsong-Hai Lee
author_sort Hsi-Lung Hsieh
collection DOAJ
description Abstract Background Intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) is the standard treatment for acute ischemic stroke. Standard-dose rt-PA (0.9 mg/kg) is known to achieve good recanalization but carries a high bleeding risk. Lower dose of rt-PA has less bleeding risk but carries a high re-occlusion rate. We investigate if induced pluripotent stem cells (iPSCs) can improve the thrombolytic effect of low-dose rt-PA (0.45 mg/kg). Methods Single irradiation with 6 mW/cm2 light-emitting diode (LED) for 4 h at rat common carotid artery was used as thrombosis model according to our previous report. Endothelin-1 (ET-1), intercellular adhesion molecule-1 (ICAM-1), and interleukin 1 beta (IL-1 beta) were used as the inflammatory markers for artery endothelial injury. Angiopoietin-2 (AP-2), brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) were examined in artery wall and iPSCs culture. Animal ultrasound was used to evaluate the stenosis degree of common carotid artery before and at 2 h, 24 h, 4 days and 7 days after LED irradiation. Results After LED irradiation alone, there was a persistent occlusion from 2 h to 7 days. Standard-dose rt-PA alone could recanalize the occluded artery from 24 h to 7 days to stenotic degree ≤ 50%. Low-dose rt-PA or 1 × 106 mouse iPSCs alone could not recanalize the occluded arteries from 2 h to 7 days. Combination use of low-dose rt-PA plus 1 × 106 mouse iPSCs caused better recanalization from 24 h to 7 days. ET-1, ICAM-1 and IL-1 beta were strongly expressed after LED irradiation but reduced after iPSCs treatment. AP-2, BDNF and VEGF were rarely induced after LED irradiation but strongly expressed after iPSCs treatment. In vitro study showed iPSCs could express AP-2, BDNF and VEGF. Conclusion The adjuvant use of iPSCs may help improving the thrombolytic effect of low-dose rt-PA by suppressing inflammatory factors and inducing angiogenic trophic factors. Stem cells could be a potential regimen in acute thrombolytic therapy to improve recanalization and reduce complications.
first_indexed 2024-12-19T03:14:34Z
format Article
id doaj.art-7cc3d14182a44c89a0e98c48a0d6a439
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-12-19T03:14:34Z
publishDate 2021-10-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-7cc3d14182a44c89a0e98c48a0d6a4392022-12-21T20:37:56ZengBMCStem Cell Research & Therapy1757-65122021-10-0112111610.1186/s13287-021-02615-zInduced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in ratHsi-Lung Hsieh0Ching-Chung Liang1Cheng-You Lu2Jen-Tsung Yang3Chiu-Yen Chung4Yu-Shien Ko5Tsong-Hai Lee6Department of Nursing, Division of Basic Medical Sciences, Research Center for Chinese Herbal Medicine, and Graduate Institute of Health Industry Technology, Chang Gung University of Science and TechnologyFemale Urology Section, Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, and College of Medicine, Chang Gung UniversityCardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationDepartment of Neurosurgery, Chia-Yi Chang Gung Memorial Hospital, Chia-Yi, Taiwan, and College of Medicine, Chang Gung UniversityDepartment of Neurosurgery, Chia-Yi Chang Gung Memorial Hospital, Chia-Yi, Taiwan, and College of Medicine, Chang Gung UniversityThe First Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Medical Center, and College of Medicine, Chang Gung UniversityStroke Center and Department of Neurology, Chang Gung Memorial Hospital, Linkou Medical Center, and College of Medicine, Chang Gung UniversityAbstract Background Intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) is the standard treatment for acute ischemic stroke. Standard-dose rt-PA (0.9 mg/kg) is known to achieve good recanalization but carries a high bleeding risk. Lower dose of rt-PA has less bleeding risk but carries a high re-occlusion rate. We investigate if induced pluripotent stem cells (iPSCs) can improve the thrombolytic effect of low-dose rt-PA (0.45 mg/kg). Methods Single irradiation with 6 mW/cm2 light-emitting diode (LED) for 4 h at rat common carotid artery was used as thrombosis model according to our previous report. Endothelin-1 (ET-1), intercellular adhesion molecule-1 (ICAM-1), and interleukin 1 beta (IL-1 beta) were used as the inflammatory markers for artery endothelial injury. Angiopoietin-2 (AP-2), brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) were examined in artery wall and iPSCs culture. Animal ultrasound was used to evaluate the stenosis degree of common carotid artery before and at 2 h, 24 h, 4 days and 7 days after LED irradiation. Results After LED irradiation alone, there was a persistent occlusion from 2 h to 7 days. Standard-dose rt-PA alone could recanalize the occluded artery from 24 h to 7 days to stenotic degree ≤ 50%. Low-dose rt-PA or 1 × 106 mouse iPSCs alone could not recanalize the occluded arteries from 2 h to 7 days. Combination use of low-dose rt-PA plus 1 × 106 mouse iPSCs caused better recanalization from 24 h to 7 days. ET-1, ICAM-1 and IL-1 beta were strongly expressed after LED irradiation but reduced after iPSCs treatment. AP-2, BDNF and VEGF were rarely induced after LED irradiation but strongly expressed after iPSCs treatment. In vitro study showed iPSCs could express AP-2, BDNF and VEGF. Conclusion The adjuvant use of iPSCs may help improving the thrombolytic effect of low-dose rt-PA by suppressing inflammatory factors and inducing angiogenic trophic factors. Stem cells could be a potential regimen in acute thrombolytic therapy to improve recanalization and reduce complications.https://doi.org/10.1186/s13287-021-02615-zCarotid thrombosisEndotheliumStem cellThrombolysisTissue plasminogen activator
spellingShingle Hsi-Lung Hsieh
Ching-Chung Liang
Cheng-You Lu
Jen-Tsung Yang
Chiu-Yen Chung
Yu-Shien Ko
Tsong-Hai Lee
Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat
Stem Cell Research & Therapy
Carotid thrombosis
Endothelium
Stem cell
Thrombolysis
Tissue plasminogen activator
title Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat
title_full Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat
title_fullStr Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat
title_full_unstemmed Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat
title_short Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat
title_sort induced pluripotent stem cells can improve thrombolytic effect of low dose rt pa after acute carotid thrombosis in rat
topic Carotid thrombosis
Endothelium
Stem cell
Thrombolysis
Tissue plasminogen activator
url https://doi.org/10.1186/s13287-021-02615-z
work_keys_str_mv AT hsilunghsieh inducedpluripotentstemcellscanimprovethrombolyticeffectoflowdosertpaafteracutecarotidthrombosisinrat
AT chingchungliang inducedpluripotentstemcellscanimprovethrombolyticeffectoflowdosertpaafteracutecarotidthrombosisinrat
AT chengyoulu inducedpluripotentstemcellscanimprovethrombolyticeffectoflowdosertpaafteracutecarotidthrombosisinrat
AT jentsungyang inducedpluripotentstemcellscanimprovethrombolyticeffectoflowdosertpaafteracutecarotidthrombosisinrat
AT chiuyenchung inducedpluripotentstemcellscanimprovethrombolyticeffectoflowdosertpaafteracutecarotidthrombosisinrat
AT yushienko inducedpluripotentstemcellscanimprovethrombolyticeffectoflowdosertpaafteracutecarotidthrombosisinrat
AT tsonghailee inducedpluripotentstemcellscanimprovethrombolyticeffectoflowdosertpaafteracutecarotidthrombosisinrat